Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 47.40M P/E - EPS this Y - Ern Qtrly Grth -
Income -228k Forward P/E -0.28 EPS next Y - 50D Avg Chg -11.00%
Sales 6.65M PEG - EPS past 5Y - 200D Avg Chg 5.00%
Dividend N/A Price/Book 1.03 EPS next 5Y - 52W High Chg -47.00%
Recommedations 3.00 Quick Ratio 3.54 Shares Outstanding 60.75M 52W Low Chg 160.00%
Insider Own - ROA -30.14% Shares Float 27.99M Beta 2.13
Inst Own 7.65% ROE -0.98% Shares Shorted/Prior 17.79K/94.95K Price 0.78
Gross Margin 100.00% Profit Margin -3.43% Avg. Volume 150,691 Target Price 2.96
Oper. Margin -408.41% Earnings Date - Volume 3,205 Change 1.30%
About Erytech Pharma S.A.

PHAXIAM Therapeutics S.A., a biopharmaceutical company, focuses on developing treatments for resistant bacterial infections in France and the United States. It develops eryaspase, which is in Phase 3 clinical development for the treatment of second-line pancreatic cancer, and in Phase 2 stage for the treatment of triple-negative breast cancer and second-line acute lymphoblastic leukemia patients. The company also engages in developing erymethionase, a preclinical product candidate that consists of methionine-?-lyase in red blood cells to target the amino acid metabolism of cancer cells and induce tumor starvation. The company was formerly known as ERYTECH Pharma S.A. and changed its name to PHAXIAM Therapeutics S.A. in June 2023. PHAXIAM Therapeutics S.A. was incorporated in 2004 and is headquartered in Lyon, France.

ERYP Chatroom

User Image Celz Posted - 8 months ago

$ERYP will delist March 11, 2024

User Image cctranscripts Posted - 10 months ago

Erytech: Mathilde Bohin / Dušan Orešanský Investor Relations Arthur Rouillé Media Relations https://www.conferencecalltranscripts.org/summary/?id=12879339 $ERYP

User Image giu_ve Posted - 11 months ago

$ERYP impressive. If you scroll down the chat see only bots posting. 😅

User Image EarningsInsider Posted - 1 year ago

ERYTECH Pharma S.A. Files SEC Form 6-K $ERYP https://www.marketbeat.com/stocks/NASDAQ/ERYP/sec-filings/

User Image cctranscripts Posted - 1 year ago

Erytech: Phaxiam Provides Business And Financial Update https://www.conferencecalltranscripts.org/summary/?id=12714794 $ERYP

User Image risenhoover Posted - 1 year ago

$ERYP / Erytech Pharma - ADR files form 6-K https://fintel.io/doc/sec-phaxiam-therapeutics-sa-1624422-6k-2023-november-16-19677-8254?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image cctranscripts Posted - 10/25/23

Erytech: Tp Icap Midcap Initiates Coverage Of Phaxiam Therapeutics With A “Buy” Recommendation https://www.conferencecalltranscripts.org/summary/?id=12639013 $ERYP

User Image cctranscripts Posted - 1 year ago

Erytech: Phxm), https://www.conferencecalltranscripts.org/summary/?id=12606902 $ERYP

User Image stockilluminati Posted - 1 year ago

$ERYP https://www.stockilluminati.com/eryp/filings.php - Erytech Pharma S.A. - American Depositary Shares files form 6-K today, check out the details.

User Image cctranscripts Posted - 1 year ago

Erytech: Phaxiam Therapeutics And Vetophage Announce Strategic Research Collaboration https://www.conferencecalltranscripts.org/summary/?id=12595216 $ERYP

User Image Quantisnow Posted - 1 year ago

$ERYP 📜 SEC Form 6-K filed by Erytech Pharma S.A. https://quantisnow.com/i/5005981?utm_source=stocktwits 45 seconds delayed.

User Image stockilluminati Posted - 09/26/23

$ERYP https://www.stockilluminati.com/eryp/filings.php - Erytech Pharma S.A. - American Depositary Shares files form 6-K today, check out the details.

User Image cctranscripts Posted - 09/26/23

Erytech: Certification Of The Person Responsible For The Half-Year Financial Report https://www.conferencecalltranscripts.org/summary/?id=12567648 $ERYP

User Image Quantisnow Posted - 09/26/23

$ERYP 📜 SEC Form 6-K filed by Erytech Pharma S.A. https://quantisnow.com/i/4988383?utm_source=stocktwits 45 seconds delayed.

User Image cctranscripts Posted - 1 year ago

Erytech: S. Aureus, P. Aeruginosa, E. Coli https://www.conferencecalltranscripts.org/summary/?id=12556840 $ERYP

User Image cctranscripts Posted - 1 year ago

Erytech: Lyon (France) And Cambridge (Ma, Us), September 18 https://www.conferencecalltranscripts.org/summary/?id=12546038 $ERYP

User Image cctranscripts Posted - 1 year ago

Report of foreign issuer [Rules 13a-16 and 15d-16] https://www.conferencecalltranscripts.org/summary/?id=12542475 $ERYP

User Image risenhoover Posted - 1 year ago

$ERYP / Erytech Pharma - ADR files form 6-K https://fintel.io/doc/sec-phaxiam-therapeutics-sa-1624422-6k-2023-september-07-19607-8824?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image cctranscripts Posted - 07/27/23

Erytech: Lyon (France) And Cambridge (Ma, Us), July 27 https://www.conferencecalltranscripts.org/summary/?id=12393525 $ERYP

User Image Quantisnow Posted - 07/27/23

$ERYP 📜 SEC Form 6-K filed by Erytech Pharma S.A. https://quantisnow.com/i/4807665?utm_source=stocktwits 45 seconds delayed.

User Image ChartMill Posted - 1 year ago

$ERYP shows quite a strong growth in Revenue. Over the last 5 years, it has been growing by 14.60% yearly. https://www.chartmill.com/stock/quote/ERYP/fundamental-analysis?key=c4b723d5-e7e0-4eb6-b924-0dc48f032dd5&utm_source=stocktwits&utm_medium=FA&utm_content=ERYP&utm_campaign=social_tracking

User Image stockilluminati Posted - 06/30/23

$ERYP https://www.stockilluminati.com/eryp/filings.php - Erytech Pharma S.A. - American Depositary Shares files form 6-K today, check out the details.

User Image EarningsInsider Posted - 06/30/23

ERYTECH Pharma S.A. Files SEC Form 6-K $ERYP https://www.marketbeat.com/stocks/NASDAQ/ERYP/sec-filings/

User Image cctranscripts Posted - 06/30/23

Erytech: Phaxiam Therapeutics https://www.conferencecalltranscripts.org/summary/?id=12324544 $ERYP

User Image Quantisnow Posted - 06/30/23

$ERYP 📜 SEC Form 6-K filed by Erytech Pharma S.A. https://quantisnow.com/i/4708693?utm_source=stocktwits 45 seconds delayed.

User Image fla Posted - 06/30/23

$ERYP [15s. delayed] filed form 6-K on June 30, 11:33:12 https://s.flashalert.me/rck9F

User Image EarningsInsider Posted - 06/30/23

ERYTECH Pharma Sees Short Interest Decrease from 37,900 shares to 17,800 shares. $ERYP https://www.marketbeat.com/stocks/NASDAQ/ERYP/short-

User Image cctranscripts Posted - 06/29/23

Erytech Pharma just filed a prospectus, suggesting it plans to soon issue some securities https://www.conferencecalltranscripts.org/summary/?id=12321457 $ERYP

User Image Quantisnow Posted - 06/29/23

$ERYP 📜 SEC Form 424B3 filed by Erytech Pharma S.A. https://quantisnow.com/i/4704292?utm_source=stocktwits 45 seconds delayed.

User Image fla Posted - 06/29/23

$ERYP [15s. delayed] filed form 424B3 on June 29, 15:52:47 https://s.flashalert.me/KJoFu

Analyst Ratings
Cowen & Co. Outperform Dec 5, 17